Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial

Autor: M B Manning, D A Streja, C Keller, C H Chung, P L Beckett, A Özdemir, Y M Cho, I Colin, L J Aronne, Erik Christiansen, Markus Laimer, L Van Gaal, S N Lederman, T M O'Connor, L J Klaff, S Aronoff, S H Baik, A V Murray, Signe O R Wallenstein, N A Godbole, H O Høivik, Dilek Gogas Yavuz, A Golay, G T'Sjoen, B Delgado, I N El Ebrashy, E S Kang, C Wium, Bruce W. Bode, Ramazan Sari, B A Palchick, J Geohas, P R Nicol, M Winnie, N Aladağ, E W Braun, C Vercammen, S A Shelbaya, K Sivalingam, S Gorban de Lapertosa, E Riffer, F G Eliaschewitz, J B Buse, B Schultes, C H Sorli, K-W Lee, Mark Warren, T Pieber, S Stäuble, R Prager, A Mertens, A A Arif, D C Eagerton, A Scheen, I J Kim, J A Seo, S Ong, E Ataoglu, John B. Buse, D Berker, A White, F Helland, J C LaRocque, Young Min Cho, Christin L. Hertz, E M Palace, L H S Canani, M P Finneran, S H A Khalil, H L Gulseth, D Weiss, J Condit, E Fließer-Görzer, L Rista, S Akın, M H M F El Hefnawy, N H Kim, C Issa, S Bilz, H Bays, S Fischli, V Preumont, J Pereles-Ortiz, B Bode, E J Morawski, Aytekin Oguz, J Cooper, Tamer Tetiker, Ann Mertens, G Rudofsky, Thomas R. Pieber, W R Litchfield, J L Gross, D L Weinstein

Publikováno v: The lancet. Diabetesendocrinology. 7(7)

BACKGROUND: Oral semaglutide is the first oral formulation of a glucagon-like peptide-1 (GLP-1) receptor agonist developed for the treatment of type 2 diabetes. We aimed to compare the efficacy and safety of flexible dose adjustments of oral semaglut

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e132376f3cbf48c52376523aef27e59f
https://pubmed.ncbi.nlm.nih.gov/31320282

Efficacy and safety of azithromycin versus phenoxymethylpenicillin in the treatment of acute maxillary sinusitis

Autor: Rolf Haye, H. O. Høivik, E. Lingaas, T. Ødegård

Publikováno v: European Journal of Clinical Microbiology & Infectious Diseases. 15:849-853

In the treatment of acute maxillary sinusitis, azithromycin offers an advantage over phenoxymethylpenicillin in that a complete course of treatment requires drug administration once daily for only three days. In this double-blind, parallel-group, mul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40942ca77313a76ddbb5360e09d08da1
https://doi.org/10.1007/bf01691214

[Combined analgesics in myalgia of the neck. A double-blind comparison of paracetamol and orphenadrine (Norgesic) and paracetamol and codeine (Paralgin forte) in general practice]

Autor: H O, Høivik, R, Gundersen, K, Osmundsen

Publikováno v: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 106(2)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::496b4f93e696f6c55e37d94359c410bf
https://pubmed.ncbi.nlm.nih.gov/3513364

[Effect of orphenadrine/paracetamol combination tablets (Norgesic) on myalgia. A double-blind comparative study using a placebo in general practice]

Autor: H O, Høivik, N, Moe, K, Osmundsen

Publikováno v: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 103(6)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d32c8d39801b526cccf292b9f62084c7
https://pubmed.ncbi.nlm.nih.gov/6346583

Lack of efficacy of the selective iNOS inhibitor GW274150 in prophylaxis of migraine headache.

Autor: Høivik, Hans Olav¹, Laurijssens, Bart E², Harnisch, Lutz O², Twomey, Colleen K³, Dixon, Ruth M², Kirkham, Andrew JT², Williams, Pauline M², Wentz, Alison L⁴, Lunnon, Martin W²

Publikováno v: Cephalalgia. Dec2010, Vol. 30 Issue 12, p1458-1467. 10p.